HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,757,391 | +1.7% | 72,183 | -4.0% | 0.02% | +14.3% |
| Q2 2023 | $2,710,768 | -12.3% | 75,153 | -7.1% | 0.02% | -19.2% |
| Q1 2023 | $3,089,341 | -31.0% | 80,894 | +2.8% | 0.03% | -33.3% |
| Q4 2022 | $4,478,087 | +66.5% | 78,701 | +15.8% | 0.04% | +56.0% |
| Q3 2022 | $2,689,000 | -21.5% | 67,992 | -12.7% | 0.02% | -7.4% |
| Q2 2022 | $3,427,000 | -1.2% | 77,886 | -10.5% | 0.03% | +28.6% |
| Q1 2022 | $3,469,000 | +8.2% | 86,985 | +9.2% | 0.02% | +23.5% |
| Q4 2021 | $3,205,000 | -14.6% | 79,692 | -13.6% | 0.02% | -26.1% |
| Q3 2021 | $3,751,000 | -9.0% | 92,204 | +1.6% | 0.02% | -4.2% |
| Q2 2021 | $4,121,000 | +12.9% | 90,746 | +3.6% | 0.02% | 0.0% |
| Q1 2021 | $3,651,000 | -5.3% | 87,565 | -3.0% | 0.02% | 0.0% |
| Q4 2020 | $3,854,000 | +1017.1% | 90,228 | +369.9% | 0.02% | +700.0% |
| Q1 2020 | $345,000 | -89.0% | 19,201 | -88.0% | 0.00% | -62.5% |
| Q1 2018 | $3,138,000 | -3.8% | 160,173 | -0.4% | 0.01% | 0.0% |
| Q4 2017 | $3,261,000 | -12.0% | 160,847 | -24.6% | 0.01% | -11.1% |
| Q3 2017 | $3,707,000 | +36.0% | 213,429 | +0.3% | 0.01% | +28.6% |
| Q2 2017 | $2,726,000 | +14.3% | 212,694 | +15.5% | 0.01% | +16.7% |
| Q1 2017 | $2,385,000 | +14.1% | 184,124 | -13.0% | 0.01% | 0.0% |
| Q4 2016 | $2,090,000 | -24.9% | 211,558 | -8.1% | 0.01% | -33.3% |
| Q3 2016 | $2,782,000 | +27.1% | 230,263 | -9.2% | 0.01% | +28.6% |
| Q2 2016 | $2,188,000 | -13.7% | 253,563 | -5.3% | 0.01% | -12.5% |
| Q1 2016 | $2,536,000 | -49.7% | 267,806 | -7.9% | 0.01% | -46.7% |
| Q4 2015 | $5,038,000 | -0.3% | 290,713 | -22.8% | 0.02% | -6.2% |
| Q3 2015 | $5,055,000 | -41.6% | 376,382 | -1.7% | 0.02% | -23.8% |
| Q2 2015 | $8,649,000 | +58.0% | 383,039 | -0.1% | 0.02% | +61.5% |
| Q1 2015 | $5,474,000 | +35.2% | 383,367 | -8.6% | 0.01% | +30.0% |
| Q4 2014 | $4,049,000 | +37.3% | 419,567 | +29.5% | 0.01% | +42.9% |
| Q3 2014 | $2,949,000 | +0.4% | 324,094 | +9.0% | 0.01% | 0.0% |
| Q2 2014 | $2,938,000 | -27.7% | 297,357 | -7.1% | 0.01% | -41.7% |
| Q1 2014 | $4,063,000 | +12.6% | 319,915 | +33.0% | 0.01% | +9.1% |
| Q4 2013 | $3,607,000 | +0.3% | 240,595 | -26.1% | 0.01% | -15.4% |
| Q3 2013 | $3,596,000 | +33.9% | 325,742 | -3.7% | 0.01% | +18.2% |
| Q2 2013 | $2,685,000 | – | 338,202 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |